Kailera Therapeutics, Inc.

Contributing Author

Recent Articles by Kailera Therapeutics, Inc.

Aug-12	Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates KLRA GlobeNewswire
Aug-11	Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer KLRA GlobeNewswire
Jul-07	Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535 KLRA GlobeNewswire
Jun-29	Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer KLRA GlobeNewswire
Jun-05	Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026 KLRA -7.72% GlobeNewswire
May-28	Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference KLRA GlobeNewswire
May-26	Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates KLRA GlobeNewswire
May-13	Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions KLRA -5.34% GlobeNewswire
Apr-20	Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares KLRA -5.35% GlobeNewswire